The mortality impacts of fine particles in France

Worldwide, air pollution has become a main environmental cause of premature mortality. This burden is largely due to fine particles. Recent cohort studies have confirmed the health risks associated with chronic exposure to PM2.5 for European and French populations. We assessed the mortality impact of PM2.5 in continental France using these new results. Based on a meta-analysis of French and European cohorts, we computed a shrunken estimate of PM2.5–mortality relationship for the French population (RR 1.15 [1.05:1.25] for a 10μg/m3 increase in PM2.5). This RR was applied to PM2.5 annual concentrations estimated at a fine spatial scale, using a classical health impacts assessment method. The health benefits associated with alternative scenarios of improving air quality were computed for 36,219 French municipalities for 2007–2008. 9% of the total mortality in continental France is attributable to anthropogenic PM2.5. This represents >48,000 deaths per year, and 950,000years of life lost per year, more than half occurring in urban areas larger than 100,000 inhabitants. If none of the municipalities exceeded the World Health Organization guideline value for PM2.5 (10μg/m3), the total mortality could be decreased by 3%, corresponding to 400,000years of life saved per year. Results were consistent with previous estimates of the long-term mortality impacts of fine particles in France. These findings show that further actions to improve air quality in France would substantially improve health. [Display omitted] •A fine-scale air quality model was used to assess the mortality impact of PM2.5 in France.•Anthropogenic PM2.5 are responsible for 9% of the total mortality in France.•Results are consistent with previous assessments while using different methods and datasets.•Further actions to improve air quality in France would substantially improve health.